A new study reveals that certain common medications may significantly alter gut microbiome composition, potentially impacting metabolic health. Researchers found that these drugs—widely prescribed for conditions like diabetes and obesity—disrupt beneficial bacteria linked to digestion and immunity. The findings suggest long-term use could contribute to unintended metabolic side effects, raising questions about alternative treatments. Experts emphasize the need for further investigation into how these interactions affect patient outcomes.